Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Conservative Pharmacotherapy Versus Staged Percutaneous Coronary Intervention on Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease

NCT02154919 is registered in ClinicalTrials.gov with Beijing Shijitan Hospital, Capital Medical University as lead sponsor.

NCT NCT02154919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02154919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Conservative Pharmacotherapy Versus Staged Percutaneous Coronary Intervention on Non-culprit Vessels for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease
Lead sponsor
Beijing Shijitan Hospital, Capital Medical University
Phase
Observational
Overall status
Completed
Start date
April 30, 2011
Completion date
Not reported
Enrollment
306 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

conservative pharmacotherapy, non-culprit vessels, st-segment elevation myocardial infarction, staged percutaneous coronary intervention